Search results
Results From The WOW.Com Content Network
Soluble guanylyl cyclase (sGC) is one of the gasoreceptors for nitric oxide, NO. It is soluble, i.e. completely intracellular. It is soluble, i.e. completely intracellular. Most notably, this enzyme is involved in vasodilation .
Soluble guanylate cyclase (sGC) stimulators are a class of drugs developed to treat heart failure, pulmonary hypertension, and other diseases. The first-in-class medication was riociguat , approved in 2013 for pulmonary hypertension.
The SGC has (so far) contributed ~120 chemical probes [10] [32] [33] into the public domain over the past decade, and >25,000 samples of these probes have been distributed to the scientific community. The chemical probes conform to the now community-standard quality criteria created by the SGC and its collaborative network. [10] [34] [35] [36 ...
SGC may refer to: Science and technology. Satellite ground station; Server-Gated Cryptography; Soluble guanylate cyclase (sGC) Standard Geographical Classification ...
SGC SGC Aviation: SAINT GEORGE Austria 2014 [1] SCJ Siamjet Aviation: SIAMJET Thailand 2014 [1] SIX Sixt Rent A Car: DRIVE ORANGE United States 2014 [1] SOG Solenta Aviation Ghana: Ghana 2014 [1] QSR SR Jet: SPARKLE ROLL China 2014 [1] KBN Spiracha Aviation: KABIN Thailand 2014 [1] CBN Southern Illinois University as "Aviation Flight ...
Server-Gated Cryptography (SGC), also known as International Step-Up by Netscape, is a defunct mechanism that was used to step up from 40-bit or 56-bit to 128-bit cipher suites with SSL. It was created in response to United States federal legislation on the export of strong cryptography in the 1990s. [ 1 ]
Solid ground curing (SGC) is a photo-polymer-based additive manufacturing (or 3D printing) [1] technology used for producing models, prototypes, patterns, and production parts, in which the production of the layer geometry is carried out by means of a high-powered UV lamp through a mask.
The first nitric oxide (NO) independent, haem-dependent sGC stimulator, YC-1, a synthetic benzylindazole derivative, was described in 1978. [14] The characterisation 20 years later demonstrated that as well as increasing sGC activity, YC-1 acted in synergy with NO to stimulate sGC. However, YC-1 was a relatively weak vasodilator and had side ...